企业邮箱
首例指控诺贝尔奖组织离间和不正当竞争的官司
1、告状申明 ：Complaint.pd
2012年-12月-06日
起源：加州洛杉矶报路
1、告状申明 ：Complaint.pdf
2、法院传票 ：Summons.pdf
FIRST SUIT AGAINST NOBEL PRIZE ORGANIZATION
CITING DEFAMATION AND UNFAIR COMPETITION PRACTICES IS FILED
首例指控诺贝尔奖组织离间和不正当竞争的官司
Los Angeles, CA, December 4, 2012 — Dr. Rongxiang Xu, the founder of “human body regenerative restoration science” and a renowned life scientist and medical scientist, has filed a lawsuit today against The Nobel Assembly at Karolinska Institutet, a Swedish corporation, aka, Nobelforsamlingen. The Nobel Assembly at Karolinska Institutet is a body which awards the Nobel Prize in Physiology or Medicine. The suit filed in Superior Court of the State of California, Orange County Central Justice Center cites Libel and unfair competition.
2012年12月4日，加州洛杉矶 --人体再生复原科学缔造人，驰名的性命科学家和医学家徐荣祥博士于今日提交官司告状瑞典卡罗林斯卡学院诺贝尔委员会，后者掌管评比和宣告诺贝尔生理学或医学奖。官司提交到加州高档法院，橙县中心法庭，指控离间和不正当竞争。
Dr. Xu, one of the leading scientists in the world, discovered “regenerative cell” in 1984 during his study of burn treatments that has benefited 20 million burn victims in 73 countries, claims his good reputation in the community was defamed by a statement published by defendants, The Nobel Assembly causing damages to Dr. Xu by their conduct. The suit alleges the Nobel Assembly has been successful in garnering media attention for their Nobel Prize announcements in essentially every major news organizations and publications world-wide, proving they can affect the perception of an individual by misreporting information.
徐博士是世界顶尖科学家之一，于1984年在其医治烧伤的钻研中发现了“再生细胞”，其烧伤疗法已在73个国度造福了2000万烧伤患者。徐博士指控被告诺贝尔委员会颁布的申明对其造成了中伤，诽谤了其在业内的优良名誉。官司指控诺贝尔委员会成功吸引了世界上险些所有主流新闻机构和出版物关注其颁奖布告，证明他们的谬误报路会影响公共的见解。
“My main priority for filing this suit was to clarify the Academy’s mistaken and misleading statements for the preservation of humanity and future generations, life science research should not desecrate the nature of human life.” stated Dr. Xu.
徐博士宣称，“我提告的重要启程点是为；と死嗉捌湮蠢词来吻灞桓嫖蟮夹缘拿笊昝，性命科学钻研不能亵渎人类性命的属性。”
On October 8, 2012, The Nobel Prize in Physiology or Medicine 2012 was awarded jointly to Sir John B. Gurdon and Shinya Yamanaka “for the discovery that mature cells can be reprogrammed to become pluripotent,” which was covered extensively in the media.
2012年10月8号，诺贝尔生理学或医学奖授予了约翰·戈登和山中伸弥先生，赞美他们“发现成熟细胞可能被重编程而出现多能性”，媒体对此进行了宽泛报路。
Furthermore, in an abstract published on its website made in conjunction with the selection, the Nobel Assembly described the scientists’ discovery. In the description, the Nobel Assembly claims that the scientists’ discovery “represents a paradigm shift in our understanding of cellular differentiation and of the plasticity of the differentiated state.” The abstract goes on to claim that: “[t]ogether, Gurdon and Yamanaka have transformed our understanding of cellular differentiation. They have demonstrated that the usually very stable differentiated state can be unlocked because it harbours a potential for reversion to pluripotency. This discovery has introduced fundamentally new research areas, and offers exciting new opportunities to study disease mechanisms.”
此表，在其网页上颁发的与评奖相连的提要里，诺贝尔委员会宣称获奖科学家的发现“代表我们对细胞分化和分化后状态可塑性的理解发生了模式转变”，接着又说“戈登和山中共同扭转了我们对细胞分化的理解。他们证了然细胞分化后通常很不变的状态可能被解锁由于它藏有逆转回多能性的潜力。这一发现开启了全新的钻研领域，并为钻研疾病机理提供了令人兴奋的新机遇。”
Dr. Xu believes, and alleges the Statement made by the Nobel Assembly is false as he was the scientist who made the discovery a decade earlier, therefore defaming his exemplary reputation. The Nobel Assembly states that the scientists who won the Nobel Prize “have transformed our understanding of cellular differentiation” because “[t]hey have demonstrated that the usually very stable differentiated state can be unlocked because it harbours a potential for reversion to pluripotency.” Those scientists did not demonstrate as such. It was ten years earlier that Dr. Xu made that discovery when he was able to explain how his discovery unlocked a somatic cell’s potential to revert to pluripotent stem cell in situ.
徐博士相信并指控诺贝尔委员会的申明是谬误的，中伤了他作为范例的名誉，由于申明里的发现是他在十年前做出的。诺贝尔委员会宣称获奖科学家的发现 “扭转了我们对细胞分化的理解”，由于“他们证了然细胞分化后通常很不变的状态可能被解锁由于它藏有逆转回多能性的潜力。”那些科学家没有证明这一点，这是徐博士在十年前可能诠释出他发现的解锁体细胞潜能使其原位逆转回多能干细胞时发现的。
The Nobel Assembly’s use of the word “unlocked” compounds the falsity of the statement because it suggests that the scientists who won the Nobel Prize are harnessing an inherent ability of a somatic cell to revert to its pluripotent state through natural means that do not alter the cells integrity. If the Nobel Prize scientists’ findings consisted of leaving a somatic cell intact and unmodified, such as Dr. Xu’s finding, then the Statement would have been true and accurate. However, the Nobel Prize scientists’ discovery actually consists of the creation of an altered cell having nothing to do with human body pluripotent stem cell. The Academy also falsely stated that “[t]his discovery has introduced fundamentally new research areas, and offers exciting new opportunities to study disease mechanisms” which is also inaccurate.
诺贝尔委员会使用“解锁」剽个字眼组成了不实申明，由于它意味着获奖的科学家是利用体细胞固有的能力通过不扭转细胞齐全性的天然的方式逆转回多能性状态。若是获奖科学家的发现可能像徐博士所做的那样，维持体细胞的齐全性不合其进行人为刷新，那么这个申明才会是真实的、正确的。但是，这些获奖科学家的发现现实上是造作了一个与多能干细胞毫无关系的刷新细胞。颁奖机构还谬误的宣称“这一发现开启了全新的钻研领域，并为钻研疾病机理提供了令人兴奋的新机遇”，这也是不合的。
Lastly, The Statements made by the defendant has falsely tainted and damaged Dr. Xu’s achievements in the eyes of the scientific community, business, potential investors and his ability to continue to be selected as a top keynote speaker for several major international conferences.
最后，被告的谬误申明玷污和侵害了在科学界商界以及潜在投资人心目中徐博士的成就及其持续被选为主流国际会议主讲人的机遇。